Microtubule Inhibitor [EPC]

Microtubule Inhibitor [EPC] was reported 165857 times

Drugs of the Microtubule Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LACRIMAL STRUCTURE INJURY 268 0.7109
1 HAIR DISORDER 5637 0.6834
2 MADAROSIS 6742 0.5803
3 HAIR COLOUR CHANGES 5883 0.4723
4 PSEUDOCIRRHOSIS 156 0.4699
5 HAIR TEXTURE ABNORMAL 5997 0.4479
6 NAIL TOXICITY 130 0.4333
7 PIK3CA-ACTIVATED MUTATION 99 0.2982
8 HER2 POSITIVE BREAST CANCER 107 0.2853
9 UROGENITAL FISTULA 67 0.2827
10 IMMUNE-MEDIATED HYPERTHYROIDISM 59 0.2323
11 RECALL PHENOMENON 189 0.2261
12 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 180 0.2258
13 AMAUROSIS FUGAX 240 0.2228
14 METASTASES TO SKIN 217 0.2101
15 AORTITIS 138 0.2012
16 DACRYOSTENOSIS ACQUIRED 256 0.1981
17 OESOPHAGEAL FISTULA 62 0.1950
18 ONYCHOLYSIS 303 0.1937
19 BILIARY TRACT INFECTION 119 0.1913
20 METASTASES TO THE MEDIASTINUM 77 0.1869
21 METASTASES TO PLEURA 188 0.1792
22 PORTAL VENOUS GAS 65 0.1791
23 COMPUTERISED TOMOGRAM THORAX ABNORMAL 118 0.1718
24 MYELOSUPPRESSION 6184 0.1715
25 ALOPECIA AREATA 294 0.1674
26 HORMONE-REFRACTORY PROSTATE CANCER 196 0.1650
27 IMMUNE-MEDIATED HYPOTHYROIDISM 186 0.1649
28 PERIPHERAL SENSORY NEUROPATHY 948 0.1620
29 IMMUNE-MEDIATED DERMATITIS 163 0.1617
30 HEPATIC ATROPHY 72 0.1607
31 RADIATION OESOPHAGITIS 61 0.1601
32 NAIL DYSTROPHY 89 0.1589
33 TRIPLE NEGATIVE BREAST CANCER 104 0.1545
34 IMMUNE-MEDIATED HYPOPHYSITIS 68 0.1508
35 DELUSION OF GRANDEUR 66 0.1470
36 RADIATION SKIN INJURY 170 0.1466
37 CYSTOID MACULAR OEDEMA 269 0.1426
38 NEUTROPENIC INFECTION 134 0.1400
39 IMMUNE-MEDIATED LUNG DISEASE 255 0.1397
40 IMMUNE-MEDIATED HEPATITIS 274 0.1341
41 ENTEROCOLITIS INFECTIOUS 123 0.1333
42 METASTASES TO LYMPH NODES 890 0.1317
43 IMMUNE-MEDIATED HEPATIC DISORDER 251 0.1286
44 GRANULOCYTE COUNT DECREASED 238 0.1282
45 BILIARY SEPSIS 59 0.1274
46 METASTASES TO PERITONEUM 320 0.1266
47 ACUTE INTERSTITIAL PNEUMONITIS 66 0.1264
48 ACUTE PROMYELOCYTIC LEUKAEMIA 127 0.1235
49 LYMPHANGIOSIS CARCINOMATOSA 125 0.1200
50 PANCREATIC CARCINOMA METASTATIC 341 0.1198
51 HEART FAILURE WITH REDUCED EJECTION FRACTION 64 0.1196
52 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 105 0.1196
53 RADIATION PNEUMONITIS 255 0.1190
54 INFUSION RELATED HYPERSENSITIVITY REACTION 70 0.1165
55 NEUTROPENIC SEPSIS 832 0.1164
56 IMMUNE-MEDIATED ENCEPHALITIS 61 0.1153
57 NEUTROPENIC COLITIS 234 0.1130
58 METASTASES TO MENINGES 257 0.1129
59 METASTASES TO BONE 1804 0.1098
60 MYOCARDIAL INJURY 121 0.1076
61 NON-SMALL CELL LUNG CANCER 512 0.1068
62 POLYNEUROPATHY 1276 0.1065
63 BREAST CANCER RECURRENT 332 0.1050
64 METASTASES TO LUNG 1212 0.1048
65 OVARIAN CANCER METASTATIC 89 0.1047
66 BREAST CANCER METASTATIC 1121 0.1043
67 DILATED CARDIOMYOPATHY 105 0.1039
68 HAEMATOTOXICITY 980 0.1030
69 FEBRILE NEUTROPENIA 6665 0.1004
70 METASTASES TO LIVER 1757 0.0999
71 IMMUNE-MEDIATED ENTEROCOLITIS 366 0.0994
72 DEFORMITY 924 0.0988
73 CAPILLARY LEAK SYNDROME 204 0.0986
74 SKIN TOXICITY 556 0.0983
75 PSYCHOLOGICAL TRAUMA 842 0.0975
76 TUMOUR NECROSIS 103 0.0974
77 METASTASES TO ADRENALS 89 0.0964
78 IMMUNE-MEDIATED MYOCARDITIS 155 0.0959
79 ALOPECIA 18607 0.0947
80 OVARIAN CANCER RECURRENT 150 0.0933
81 METASTASES TO CENTRAL NERVOUS SYSTEM 1197 0.0927
82 NON-SMALL CELL LUNG CANCER METASTATIC 81 0.0922
83 CARBOHYDRATE ANTIGEN 15-3 INCREASED 70 0.0920
84 PERIPHERAL MOTOR NEUROPATHY 128 0.0913
85 ALVEOLITIS 128 0.0906
86 SYSTEMIC SCLERODERMA 65 0.0893
87 INVASIVE DUCTAL BREAST CARCINOMA 241 0.0886
88 MUCOSAL INFLAMMATION 2320 0.0885
89 GASTROINTESTINAL TOXICITY 422 0.0878
90 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 107 0.0859
91 ANASTOMOTIC LEAK 59 0.0850
92 SUBCLAVIAN VEIN THROMBOSIS 92 0.0808
93 GASTROINTESTINAL PERFORATION 329 0.0790
94 CARDIOTOXICITY 694 0.0777
95 LEFT VENTRICULAR DYSFUNCTION 520 0.0776
96 THERAPY PARTIAL RESPONDER 1187 0.0760
97 MALIGNANT PLEURAL EFFUSION 127 0.0752
98 NEUTROPHIL COUNT DECREASED 3018 0.0740
99 PROSTATE CANCER METASTATIC 247 0.0739
100 HYPERSENSITIVITY PNEUMONITIS 84 0.0737
101 PNEUMONITIS 1968 0.0722
102 EJECTION FRACTION DECREASED 1120 0.0720
103 NEOPLASM RECURRENCE 239 0.0704
104 METASTASES TO SPINE 236 0.0702
105 FEBRILE INFECTION 82 0.0697
106 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1612 0.0691
107 HYPOPITUITARISM 120 0.0689
108 HYDROTHORAX 57 0.0687
109 MALIGNANT NEOPLASM PROGRESSION 6969 0.0680
110 TUMOUR PAIN 87 0.0660
111 PULMONARY TOXICITY 467 0.0660
112 HYPOPHYSITIS 132 0.0656
113 SENSE OF OPPRESSION 76 0.0646
114 PARONYCHIA 281 0.0639
115 LYMPHADENOPATHY MEDIASTINAL 122 0.0636
116 NEUTROPENIA 8608 0.0632
117 TUMOUR HAEMORRHAGE 180 0.0630
118 CARDIAC DYSFUNCTION 234 0.0628
119 METASTASIS 446 0.0624
120 FULMINANT TYPE 1 DIABETES MELLITUS 64 0.0621
121 LICHENOID KERATOSIS 141 0.0617
122 SECOND PRIMARY MALIGNANCY 513 0.0616
123 BILE DUCT STENOSIS 73 0.0609
124 IMMUNE-MEDIATED ADVERSE REACTION 93 0.0605
125 CHOLANGITIS 375 0.0604
126 ENTEROCOLITIS 348 0.0602
127 LEUKOPENIA 3008 0.0601
128 ONYCHALGIA 60 0.0598
129 DEVICE RELATED THROMBOSIS 58 0.0588
130 NEUROTOXICITY 1029 0.0587
131 BONE MARROW FAILURE 1189 0.0585
132 INFECTIOUS PLEURAL EFFUSION 89 0.0584
133 BREAST NEOPLASM 60 0.0581
134 DUODENAL PERFORATION 57 0.0580
135 HYPERTRANSAMINASAEMIA 401 0.0576
136 TUMOUR PSEUDOPROGRESSION 63 0.0575
137 NEUROPATHY PERIPHERAL 5449 0.0572
138 LYMPHOCYTE COUNT ABNORMAL 64 0.0568
139 SEROMA 72 0.0566
140 ACUTE MYELOID LEUKAEMIA 880 0.0564
141 FEMALE GENITAL TRACT FISTULA 96 0.0562
142 SMALL INTESTINAL PERFORATION 105 0.0559
143 JUGULAR VEIN THROMBOSIS 99 0.0556
144 CHOLANGITIS SCLEROSING 112 0.0545
145 INTERSTITIAL LUNG DISEASE 2640 0.0545
146 ADENOCARCINOMA 120 0.0535
147 PNEUMATOSIS INTESTINALIS 152 0.0532
148 URINARY TRACT DISORDER 239 0.0530
149 ADENOCARCINOMA PANCREAS 68 0.0529
150 FEBRILE BONE MARROW APLASIA 224 0.0527
151 LARGE INTESTINE PERFORATION 366 0.0527
152 HYPOPROTEINAEMIA 99 0.0521
153 OSTEOSCLEROSIS 82 0.0520
154 GASTROINTESTINAL NECROSIS 151 0.0517
155 NAIL DISORDER 453 0.0517
156 DISEASE PROGRESSION 6109 0.0516
157 EMBOLISM 428 0.0515
158 NEOPLASM PROGRESSION 1792 0.0515
159 BONE MARROW TOXICITY 60 0.0506
160 HEPATITIS B REACTIVATION 159 0.0500
161 HYPOALBUMINAEMIA 387 0.0497
162 METASTATIC NEOPLASM 212 0.0491
163 BONE LESION 177 0.0490
164 LYMPHOEDEMA 334 0.0483
165 THYROIDITIS 145 0.0482
166 SUBILEUS 99 0.0475
167 MASTECTOMY 83 0.0474
168 ACQUIRED GENE MUTATION 62 0.0473
169 DYSAESTHESIA 145 0.0473
170 LUNG ADENOCARCINOMA 142 0.0471
171 GASTRIC PERFORATION 128 0.0469
172 RADIOTHERAPY 89 0.0465
173 DERMATOMYOSITIS 117 0.0461
174 TROPONIN I INCREASED 75 0.0450
175 HAEMOLYTIC URAEMIC SYNDROME 104 0.0448
176 ORGANISING PNEUMONIA 219 0.0441
177 OSTEOLYSIS 90 0.0440
178 OTOTOXICITY 81 0.0438
179 HYPOMAGNESAEMIA 607 0.0436
180 PSEUDOMEMBRANOUS COLITIS 97 0.0434
181 MYELODYSPLASTIC SYNDROME 626 0.0432
182 ASCITES 1265 0.0430
183 CANCER PAIN 110 0.0430
184 DERMATITIS ACNEIFORM 261 0.0429
185 NAIL DISCOLOURATION 168 0.0427
186 ADRENAL INSUFFICIENCY 514 0.0423
187 HYPERPYREXIA 178 0.0420
188 PNEUMOCYSTIS JIROVECII PNEUMONIA 422 0.0420
189 BICYTOPENIA 82 0.0418
190 STRESS CARDIOMYOPATHY 243 0.0417
191 HEPATIC CYTOLYSIS 532 0.0417
192 PERFORMANCE STATUS DECREASED 193 0.0413
193 HEPATIC LESION 178 0.0411
194 VASCULAR DEVICE INFECTION 186 0.0410
195 LUNG ABSCESS 86 0.0410
196 ANHEDONIA 1069 0.0406
197 THROMBOTIC MICROANGIOPATHY 396 0.0406
198 HYDRONEPHROSIS 303 0.0404
199 SECONDARY ADRENOCORTICAL INSUFFICIENCY 61 0.0404
200 HYPERAEMIA 79 0.0401
201 TYPE I HYPERSENSITIVITY 140 0.0397
202 HAEMORRHAGIC STROKE 307 0.0393
203 MYOSITIS 348 0.0387
204 SYSTEMIC INFECTION 64 0.0386
205 THROMBOCYTOPENIA 4296 0.0384
206 GENE MUTATION 76 0.0384
207 SOFT TISSUE INFECTION 70 0.0382
208 INTESTINAL ISCHAEMIA 210 0.0381
209 OESOPHAGITIS 415 0.0379
210 DIFFUSE ALOPECIA 69 0.0371
211 PROTEINURIA 699 0.0367
212 MACULAR OEDEMA 206 0.0367
213 MYOCARDITIS 419 0.0365
214 HEPATIC FUNCTION ABNORMAL 1358 0.0364
215 GENERALISED OEDEMA 450 0.0363
216 IMPAIRED QUALITY OF LIFE 520 0.0361
217 ANAEMIA 6889 0.0361
218 NEUTROPHIL COUNT ABNORMAL 102 0.0361
219 LIVER ABSCESS 117 0.0360
220 HYPOKALAEMIA 1642 0.0355
221 VENA CAVA THROMBOSIS 59 0.0355
222 CYSTITIS HAEMORRHAGIC 143 0.0354
223 AGRANULOCYTOSIS 657 0.0353
224 DISSEMINATED INTRAVASCULAR COAGULATION 496 0.0352
225 PNEUMOTHORAX 551 0.0347
226 EMBOLISM VENOUS 105 0.0346
227 TUMOUR LYSIS SYNDROME 303 0.0344
228 PORTAL HYPERTENSION 106 0.0343
229 URINARY TRACT OBSTRUCTION 81 0.0341
230 CARCINOEMBRYONIC ANTIGEN INCREASED 66 0.0340
231 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 60 0.0337
232 PSEUDOMONAL SEPSIS 59 0.0337
233 ABDOMINAL INFECTION 86 0.0336
234 CACHEXIA 173 0.0336
235 ATELECTASIS 323 0.0334
236 COLITIS 1261 0.0332
237 LYMPHOPENIA 470 0.0332
238 APLASIA 65 0.0332
239 PLEURAL EFFUSION 2009 0.0330
240 VENOUS THROMBOSIS LIMB 68 0.0329
241 ERYTHEMA MULTIFORME 306 0.0328
242 EMPYEMA 65 0.0327
243 INTESTINAL PERFORATION 364 0.0324
244 VOCAL CORD PARALYSIS 58 0.0323
245 OSTEONECROSIS OF JAW 798 0.0322
246 HYPOCALCAEMIA 609 0.0321
247 PROSTATIC SPECIFIC ANTIGEN INCREASED 439 0.0318
248 BREAST DISORDER 65 0.0318
249 PERIODONTITIS 69 0.0318
250 HAIR GROWTH ABNORMAL 220 0.0318
251 VENOUS THROMBOSIS 124 0.0316
252 TUMOUR MARKER INCREASED 151 0.0314
253 ONYCHOMADESIS 132 0.0314
254 EXPOSED BONE IN JAW 68 0.0314
255 RECURRENT CANCER 128 0.0313
256 STOMATITIS 1886 0.0311
257 ENTERITIS 199 0.0311
258 HYPOXIA 1086 0.0308
259 WOUND DEHISCENCE 104 0.0308
260 EMOTIONAL DISTRESS 3676 0.0303
261 GRANULOCYTOPENIA 172 0.0302
262 ILEUS 373 0.0300
263 ANAPHYLACTIC SHOCK 773 0.0300
264 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 286 0.0299
265 PANCYTOPENIA 1672 0.0299
266 ESCHERICHIA BACTERAEMIA 70 0.0297
267 LARYNGOSPASM 80 0.0297
268 ERYSIPELAS 149 0.0296
269 NEPHRITIS 99 0.0296
270 DYSPNOEA AT REST 85 0.0293
271 SCLERODERMA 106 0.0291
272 OLIGOHYDRAMNIOS 97 0.0291
273 SEPTIC SHOCK 1262 0.0290
274 CARDIOMYOPATHY 425 0.0287
275 WHITE BLOOD CELL COUNT DECREASED 3106 0.0286
276 AZOTAEMIA 114 0.0285
277 CONGESTIVE CARDIOMYOPATHY 118 0.0283
278 KOUNIS SYNDROME 64 0.0282
279 HYPOTHYROIDISM 894 0.0280
280 ALANINE AMINOTRANSFERASE ABNORMAL 59 0.0279
281 ESCHERICHIA SEPSIS 81 0.0279
282 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 209 0.0278
283 ODYNOPHAGIA 165 0.0276
284 OVARIAN CANCER 253 0.0274
285 IMMUNE THROMBOCYTOPENIA 125 0.0273
286 ACUTE RESPIRATORY DISTRESS SYNDROME 482 0.0272
287 CARDIAC FAILURE ACUTE 180 0.0270
288 SUFFOCATION FEELING 67 0.0270
289 HEPATOTOXICITY 599 0.0269
290 JAUNDICE CHOLESTATIC 95 0.0269
291 SUSPECTED OFF LABEL USE 121 0.0268
292 OESOPHAGEAL STENOSIS 76 0.0267
293 INFUSION RELATED REACTION 1763 0.0266
294 TRANSAMINASES INCREASED 590 0.0265
295 LUNG CONSOLIDATION 74 0.0264
296 CYTOPENIA 323 0.0264
297 DEVICE RELATED INFECTION 405 0.0263
298 VENTRICULAR HYPOKINESIA 83 0.0258
299 FAILURE TO THRIVE 132 0.0254
300 AUTOIMMUNE HAEMOLYTIC ANAEMIA 87 0.0254
301 BRONCHOSPASM 358 0.0251
302 PULSE ABSENT 119 0.0250
303 LICHEN PLANUS 58 0.0250
304 DISCOMFORT 1521 0.0249
305 LUNG INFILTRATION 220 0.0249
306 ANAPHYLACTOID REACTION 102 0.0248
307 PERICARDIAL EFFUSION 573 0.0248
308 RASH MACULO-PAPULAR 550 0.0247
309 TOXIC SKIN ERUPTION 247 0.0245
310 HYPOVOLAEMIC SHOCK 117 0.0244
311 SMALL INTESTINAL OBSTRUCTION 300 0.0243
312 LUNG OPACITY 64 0.0243
313 PORTAL VEIN THROMBOSIS 78 0.0241
314 NEUTROPHIL COUNT INCREASED 247 0.0241
315 SEPSIS 2689 0.0241
316 HAEMOPTYSIS 667 0.0239
317 DERMATITIS BULLOUS 172 0.0237
318 LACRIMATION INCREASED 715 0.0236
319 HYPONATRAEMIA 1329 0.0236
320 HYPERBILIRUBINAEMIA 244 0.0235
321 LYMPHOCYTE COUNT DECREASED 416 0.0235
322 CEREBRAL ISCHAEMIA 121 0.0235
323 KERATITIS 71 0.0233
324 THROMBOTIC THROMBOCYTOPENIC PURPURA 82 0.0232
325 COLITIS ISCHAEMIC 157 0.0232
326 DUODENAL ULCER 164 0.0232
327 HYPOVOLAEMIA 136 0.0232
328 IMMUNE-MEDIATED MYOSITIS 64 0.0232
329 GUILLAIN-BARRE SYNDROME 112 0.0231
330 ASPARTATE AMINOTRANSFERASE INCREASED 1227 0.0231
331 TYPE 1 DIABETES MELLITUS 139 0.0231
332 PAPILLOEDEMA 104 0.0230
333 RHINALGIA 63 0.0229
334 OCULAR DISCOMFORT 257 0.0229
335 PATHOLOGICAL FRACTURE 116 0.0228
336 GENERAL PHYSICAL HEALTH DETERIORATION 2640 0.0228
337 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 233 0.0227
338 BLOOD ALKALINE PHOSPHATASE INCREASED 563 0.0226
339 NECROTISING FASCIITIS 79 0.0224
340 ALANINE AMINOTRANSFERASE INCREASED 1372 0.0223
341 CARDIAC TAMPONADE 106 0.0223
342 CATHETER SITE INFECTION 84 0.0222
343 ELECTROLYTE IMBALANCE 258 0.0222
344 EXTRAVASATION 91 0.0221
345 HYPERTHYROIDISM 320 0.0221
346 ALTERED STATE OF CONSCIOUSNESS 478 0.0220
347 GAMMA-GLUTAMYLTRANSFERASE INCREASED 487 0.0220
348 ARTERIOSPASM CORONARY 88 0.0219
349 BACTERAEMIA 260 0.0219
350 FLUSHING 2214 0.0218
351 DRUG RESISTANCE 558 0.0217
352 HYPOPHOSPHATAEMIA 160 0.0216
353 ORAL CANDIDIASIS 283 0.0215
354 LEUKOENCEPHALOPATHY 80 0.0215
355 TROPONIN INCREASED 163 0.0214
356 CLOSTRIDIUM DIFFICILE COLITIS 227 0.0214
357 TYPE IV HYPERSENSITIVITY REACTION 58 0.0212
358 PYELONEPHRITIS 182 0.0210
359 LEUKOCYTOSIS 379 0.0209
360 INJURY 1471 0.0209
361 HEPATIC FAILURE 630 0.0209
362 DRUG ERUPTION 370 0.0209
363 CYANOSIS 328 0.0208
364 UROSEPSIS 192 0.0208
365 OXYGEN SATURATION DECREASED 1168 0.0208
366 PROTEIN TOTAL DECREASED 78 0.0207
367 RENAL TUBULAR DISORDER 58 0.0206
368 LARYNGEAL OEDEMA 127 0.0206
369 PRESYNCOPE 501 0.0206
370 HYPERTRIGLYCERIDAEMIA 120 0.0205
371 ACUTE LYMPHOCYTIC LEUKAEMIA 58 0.0205
372 CLOSTRIDIAL INFECTION 69 0.0204
373 ILEUS PARALYTIC 91 0.0204
374 NEPHROPATHY TOXIC 227 0.0202
375 PLATELET COUNT DECREASED 2147 0.0201
376 LUNG CANCER METASTATIC 58 0.0201
377 ORTHOPNOEA 64 0.0201
378 OESOPHAGEAL CANDIDIASIS 80 0.0201
379 DUODENAL ULCER HAEMORRHAGE 57 0.0199
380 PULMONARY MASS 296 0.0199
381 BONE MARROW DISORDER 60 0.0198
382 SUDDEN DEATH 210 0.0198
383 NEPHROTIC SYNDROME 136 0.0198
384 PULMONARY HAEMORRHAGE 155 0.0198
385 BLOOD CREATININE DECREASED 62 0.0198
386 DERMATITIS 414 0.0197
387 HICCUPS 162 0.0197
388 ENCEPHALITIS 136 0.0196
389 THROMBOCYTOSIS 72 0.0196
390 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 65 0.0196
391 NON-CARDIAC CHEST PAIN 62 0.0196
392 BLOOD BILIRUBIN INCREASED 527 0.0195
393 RESPIRATORY FAILURE 1420 0.0195
394 LEFT VENTRICULAR FAILURE 67 0.0194
395 EPISTAXIS 1449 0.0194
396 TOXIC EPIDERMAL NECROLYSIS 291 0.0191
397 DIASTOLIC DYSFUNCTION 59 0.0191
398 THROMBOPHLEBITIS 67 0.0191
399 NECROSIS 106 0.0190
400 HAEMATEMESIS 482 0.0190
401 HYPERURICAEMIA 78 0.0190
402 MIXED LIVER INJURY 57 0.0189
403 BLOOD LACTATE DEHYDROGENASE INCREASED 300 0.0189
404 SPINAL CORD COMPRESSION 73 0.0187
405 LUNG INFECTION 290 0.0186
406 SINUS TACHYCARDIA 265 0.0186
407 PERIPHERAL ISCHAEMIA 76 0.0186
408 HYPERTHERMIA 142 0.0186
409 SUPRAVENTRICULAR TACHYCARDIA 178 0.0186
410 FOETAL GROWTH RESTRICTION 113 0.0186
411 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 71 0.0186
412 HAEMATURIA 632 0.0184
413 PYREXIA 6381 0.0184
414 CHOLECYSTITIS 219 0.0184
415 HEPATIC CYST 62 0.0182
416 ACUTE PULMONARY OEDEMA 102 0.0182
417 AUTOIMMUNE HEPATITIS 126 0.0181
418 DEHYDRATION 2413 0.0181
419 BONE PAIN 1053 0.0180
420 PULMONARY EMBOLISM 1706 0.0179
421 TACHYPNOEA 244 0.0179
422 HYPERTENSIVE CRISIS 199 0.0179
423 DISEASE RECURRENCE 850 0.0179
424 ACUTE HEPATIC FAILURE 243 0.0178
425 C-REACTIVE PROTEIN INCREASED 645 0.0177
426 CHEMOTHERAPY 67 0.0177
427 PERITONITIS 366 0.0177
428 PNEUMONIA BACTERIAL 162 0.0176
429 CARBOHYDRATE ANTIGEN 125 INCREASED 60 0.0176
430 TACHYCARDIA 1563 0.0176
431 HEPATITIS 450 0.0176
432 SHOCK HAEMORRHAGIC 143 0.0175
433 CIRCULATORY COLLAPSE 299 0.0175
434 BLOOD MAGNESIUM DECREASED 151 0.0175
435 CHEST DISCOMFORT 1788 0.0174
436 BUNDLE BRANCH BLOCK LEFT 74 0.0174
437 FIBRIN D DIMER INCREASED 62 0.0174
438 DECREASED APPETITE 4050 0.0174
439 CARDIO-RESPIRATORY ARREST 728 0.0174
440 ACUTE CORONARY SYNDROME 142 0.0171
441 LIVER INJURY 420 0.0171
442 CARDIAC FAILURE CHRONIC 72 0.0169
443 LOCALISED OEDEMA 78 0.0168
444 ANAPHYLACTIC REACTION 930 0.0168
445 ENDOCARDITIS 86 0.0168
446 BLOOD ALBUMIN DECREASED 133 0.0167
447 MITRAL VALVE INCOMPETENCE 189 0.0167
448 STAPHYLOCOCCAL BACTERAEMIA 72 0.0165
449 HYPERGLYCAEMIA 599 0.0164
450 RED CELL DISTRIBUTION WIDTH INCREASED 68 0.0164
451 BLOOD CREATINE INCREASED 72 0.0162
452 PULMONARY ALVEOLAR HAEMORRHAGE 91 0.0162
453 HEAD DISCOMFORT 287 0.0162
454 CARDIAC FAILURE 1298 0.0162
455 AUTOIMMUNE THYROIDITIS 61 0.0161
456 CHOLESTASIS 309 0.0161
457 DRUG-INDUCED LIVER INJURY 502 0.0160
458 SKIN REACTION 225 0.0160
459 HAEMOLYTIC ANAEMIA 143 0.0159
460 HYPERCALCAEMIA 196 0.0159
461 FISTULA 178 0.0158
462 MALNUTRITION 177 0.0158
463 PHLEBITIS 81 0.0158
464 CYTOKINE RELEASE SYNDROME 317 0.0158
465 SARCOIDOSIS 75 0.0158
466 MULTIPLE ORGAN DYSFUNCTION SYNDROME 446 0.0157
467 UNRESPONSIVE TO STIMULI 406 0.0157
468 HAEMOGLOBIN ABNORMAL 101 0.0157
469 DIARRHOEA 10118 0.0157
470 MYOCARDIAL ISCHAEMIA 177 0.0155
471 STAPHYLOCOCCAL SEPSIS 76 0.0154
472 HEPATITIS ACUTE 100 0.0154
473 HYPOPHAGIA 391 0.0153
474 ATRIAL FLUTTER 121 0.0151
475 ABDOMINAL ABSCESS 67 0.0151
476 LYMPHADENOPATHY 533 0.0150
477 SKIN NECROSIS 78 0.0150
478 DERMATITIS EXFOLIATIVE 75 0.0150
479 ONYCHOCLASIS 103 0.0150
480 BLEPHARITIS 60 0.0149
481 ACUTE RESPIRATORY FAILURE 287 0.0149
482 KLEBSIELLA INFECTION 75 0.0148
483 ESCHERICHIA URINARY TRACT INFECTION 63 0.0148
484 ERYTHEMA 3007 0.0146
485 PURULENT DISCHARGE 62 0.0145
486 BLOOD PRESSURE SYSTOLIC DECREASED 66 0.0145
487 SPINAL PAIN 170 0.0145
488 SKIN INFECTION 162 0.0144
489 MOUTH ULCERATION 303 0.0144
490 ISCHAEMIA 66 0.0143
491 CELLULITIS 723 0.0143
492 HYDROCEPHALUS 78 0.0143
493 PNEUMONIA ASPIRATION 357 0.0143
494 LUNG NEOPLASM 61 0.0143
495 THROAT TIGHTNESS 386 0.0143
496 SHOCK 327 0.0142
497 FEELING HOT 871 0.0142
498 VASCULITIS 165 0.0141
499 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 110 0.0141
500 PULMONARY FIBROSIS 271 0.0141
501 DEEP VEIN THROMBOSIS 916 0.0141
502 FACE OEDEMA 236 0.0140
503 IMMUNOSUPPRESSION 123 0.0139
504 VOMITING 6500 0.0138
505 ABDOMINAL PAIN 3206 0.0138
506 RESPIRATORY DISTRESS 379 0.0137
507 TUBULOINTERSTITIAL NEPHRITIS 255 0.0136
508 CEREBRAL INFARCTION 332 0.0136
509 ANXIETY 3864 0.0136
510 SUBCUTANEOUS ABSCESS 65 0.0135
511 TRICUSPID VALVE INCOMPETENCE 107 0.0135
512 HAEMATOCRIT DECREASED 266 0.0134
513 RENAL FAILURE CHRONIC 103 0.0134
514 ACUTE KIDNEY INJURY 2049 0.0134
515 GINGIVITIS 72 0.0133
516 INFLAMMATORY MARKER INCREASED 66 0.0133
517 ESCHERICHIA INFECTION 109 0.0132
518 PLEURISY 78 0.0131
519 DYSPNOEA 7433 0.0131
520 PANCREATIC CARCINOMA 379 0.0131
521 ASTHENIA 4924 0.0131
522 WHITE BLOOD CELL COUNT ABNORMAL 82 0.0128
523 APHTHOUS ULCER 99 0.0128
524 DIPLOPIA 331 0.0127
525 DYSPNOEA EXERTIONAL 478 0.0127
526 UPPER GASTROINTESTINAL HAEMORRHAGE 213 0.0126
527 BLOOD DISORDER 101 0.0126
528 HAEMOGLOBIN DECREASED 1286 0.0125
529 OEDEMA PERIPHERAL 1507 0.0124
530 SKIN DISORDER 412 0.0123
531 NEUTROPHILIA 70 0.0123
532 FACIAL PARALYSIS 104 0.0122
533 PEMPHIGOID 92 0.0122
534 ABDOMINAL TENDERNESS 60 0.0121
535 GASTROENTERITIS 175 0.0120
536 ATAXIA 142 0.0120
537 ENCEPHALOPATHY 293 0.0119
538 BLOOD CREATININE INCREASED 778 0.0119
539 PSEUDOMONAS INFECTION 102 0.0119
540 HYPERKALAEMIA 417 0.0119
541 SYNCOPE 1187 0.0119
542 GASTRITIS 312 0.0118
543 HEPATOCELLULAR INJURY 168 0.0118
544 HYPERNATRAEMIA 59 0.0118
545 CHILLS 1381 0.0118
546 BLOOD UREA INCREASED 197 0.0118
547 BREAST MASS 79 0.0118
548 BREAST PAIN 125 0.0117
549 ANAL ABSCESS 63 0.0117
550 HYPOTENSION 2343 0.0117
551 MENINGITIS 78 0.0117
552 CHOLECYSTITIS ACUTE 66 0.0116
553 DYSPHAGIA 1105 0.0116
554 STEVENS-JOHNSON SYNDROME 257 0.0115
555 LUNG DISORDER 566 0.0115
556 CANDIDA INFECTION 195 0.0115
557 OEDEMA 625 0.0115
558 SKIN HYPERPIGMENTATION 99 0.0115
559 NAUSEA 9100 0.0115
560 PHOTOPHOBIA 215 0.0114
561 HYPERTENSION 2417 0.0114
562 TASTE DISORDER 230 0.0113
563 INTRACRANIAL PRESSURE INCREASED 63 0.0113
564 CARDIOGENIC SHOCK 161 0.0112
565 BACK PAIN 2606 0.0112
566 LOW BIRTH WEIGHT BABY 89 0.0112
567 RESPIRATORY TRACT INFECTION 290 0.0111
568 DERMATITIS ALLERGIC 140 0.0111
569 PNEUMONIA 3594 0.0111
570 PERONEAL NERVE PALSY 63 0.0111
571 GINGIVAL PAIN 88 0.0110
572 MUSCULOSKELETAL CHEST PAIN 171 0.0110
573 BLOOD CALCIUM DECREASED 124 0.0110
574 ASPIRATION 120 0.0109
575 BODY TEMPERATURE INCREASED 223 0.0109
576 DIARRHOEA HAEMORRHAGIC 102 0.0109
577 MULTI-ORGAN FAILURE 188 0.0109
578 RASH PUSTULAR 79 0.0108
579 BRONCHOPULMONARY ASPERGILLOSIS 84 0.0108
580 APPENDICITIS 101 0.0108
581 DECUBITUS ULCER 88 0.0108
582 SENSORY DISTURBANCE 173 0.0108
583 BLOOD SODIUM DECREASED 203 0.0108
584 BREAST CANCER 1003 0.0108
585 INTESTINAL OBSTRUCTION 405 0.0107
586 CONSTIPATION 2343 0.0107
587 BRAIN OEDEMA 135 0.0107
588 METABOLIC DISORDER 62 0.0107
589 COMPRESSION FRACTURE 57 0.0106
590 HYPERSENSITIVITY 1971 0.0106
591 AFFECTIVE DISORDER 83 0.0105
592 ANOREXIA 135 0.0105
593 RENAL IMPAIRMENT 878 0.0104
594 BONE DISORDER 190 0.0104
595 HEPATOMEGALY 102 0.0104
596 DYSGEUSIA 766 0.0103
597 HEPATITIS B 62 0.0103
598 SPINAL COMPRESSION FRACTURE 85 0.0103
599 PANCREATITIS ACUTE 231 0.0103
600 CLOSTRIDIUM DIFFICILE INFECTION 224 0.0103
601 LIVER DISORDER 454 0.0102
602 ORAL DISORDER 75 0.0102
603 ORAL PAIN 229 0.0102
604 JAUNDICE 273 0.0101
605 RESPIRATORY RATE INCREASED 90 0.0101
606 DRUG TOXICITY 138 0.0101
607 INFECTION 1464 0.0101
608 RENAL TUBULAR NECROSIS 99 0.0101
609 PROTHROMBIN TIME PROLONGED 60 0.0100
610 ISCHAEMIC STROKE 179 0.0100
611 PULMONARY OEDEMA 448 0.0100
612 WOUND INFECTION 109 0.0099
613 SENSORY LOSS 80 0.0099
614 CENTRAL NERVOUS SYSTEM LESION 136 0.0099
615 ANURIA 85 0.0099
616 LIVER FUNCTION TEST INCREASED 212 0.0099
617 ATRIAL FIBRILLATION 961 0.0099
618 GASTROINTESTINAL DISORDER 883 0.0098
619 NEOPLASM 113 0.0098
620 MYASTHENIA GRAVIS 79 0.0098
621 ORTHOSTATIC HYPOTENSION 170 0.0098
622 HAEMODYNAMIC INSTABILITY 74 0.0097
623 GASTRIC HAEMORRHAGE 111 0.0096
624 NEURALGIA 234 0.0096
625 OSTEONECROSIS 316 0.0096
626 CONJUNCTIVITIS 178 0.0096
627 MYALGIA 1629 0.0096
628 RENAL CYST 76 0.0096
629 BLINDNESS 389 0.0095
630 WHITE BLOOD CELL COUNT INCREASED 365 0.0095
631 BLOOD PRESSURE DIASTOLIC DECREASED 70 0.0095
632 SKIN ULCER 245 0.0095
633 VENTRICULAR FIBRILLATION 105 0.0094
634 GENERAL PHYSICAL CONDITION ABNORMAL 64 0.0094
635 ACIDOSIS 72 0.0094
636 OROPHARYNGEAL DISCOMFORT 85 0.0094
637 PARAESTHESIA 1480 0.0094
638 MELAENA 207 0.0094
639 BRONCHIECTASIS 63 0.0093
640 INFUSION SITE EXTRAVASATION 58 0.0093
641 HOT FLUSH 702 0.0093
642 FATIGUE 7226 0.0093
643 ABSCESS 148 0.0093
644 LIPASE INCREASED 71 0.0093
645 DYSURIA 341 0.0093
646 HYPERAESTHESIA 76 0.0092
647 CARDIAC ARREST 760 0.0092
648 RED BLOOD CELL COUNT DECREASED 262 0.0092
649 EYELID OEDEMA 106 0.0091
650 HEPATIC STEATOSIS 169 0.0091
651 FLANK PAIN 85 0.0091
652 MOUTH HAEMORRHAGE 66 0.0090
653 ACUTE MYOCARDIAL INFARCTION 265 0.0090
654 VENTRICULAR EXTRASYSTOLES 92 0.0089
655 URINE OUTPUT DECREASED 77 0.0088
656 GASTRIC ULCER 167 0.0088
657 CHEST PAIN 1627 0.0088
658 RECTAL HAEMORRHAGE 377 0.0088
659 OFF LABEL USE 7661 0.0087
660 RENAL FAILURE ACUTE 371 0.0087
661 VISUAL FIELD DEFECT 63 0.0087
662 COUGH 2437 0.0087
663 MYOPATHY 75 0.0087
664 POST-TRAUMATIC STRESS DISORDER 58 0.0086
665 OSTEOMYELITIS 156 0.0086
666 URINARY TRACT INFECTION 1461 0.0086
667 TINNITUS 393 0.0085
668 CYSTITIS 270 0.0085
669 PHOTOSENSITIVITY REACTION 140 0.0085
670 DRUG INTOLERANCE 815 0.0084
671 HEPATIC CIRRHOSIS 158 0.0084
672 LOWER RESPIRATORY TRACT INFECTION 381 0.0084
673 BLOOD THYROID STIMULATING HORMONE INCREASED 76 0.0083
674 PETECHIAE 86 0.0082
675 RASH 3592 0.0082
676 BLOOD PRESSURE DECREASED 545 0.0082
677 SPINAL OSTEOARTHRITIS 72 0.0082
678 IMPAIRED HEALING 268 0.0082
679 DEPRESSED LEVEL OF CONSCIOUSNESS 322 0.0081
680 STAPHYLOCOCCAL INFECTION 268 0.0081
681 LOWER GASTROINTESTINAL HAEMORRHAGE 60 0.0081
682 TOOTH EXTRACTION 101 0.0081
683 PRODUCT USE IN UNAPPROVED INDICATION 2003 0.0081
684 SKIN LESION 221 0.0080
685 GINGIVAL BLEEDING 110 0.0080
686 BLOOD POTASSIUM DECREASED 242 0.0080
687 MENTAL STATUS CHANGES 223 0.0080
688 COMA 381 0.0080
689 PREMATURE DELIVERY 126 0.0079
690 URINARY RETENTION 263 0.0079
691 DIABETIC KETOACIDOSIS 189 0.0079
692 ARTERIOSCLEROSIS 74 0.0079
693 ASPHYXIA 64 0.0078
694 RHINITIS 63 0.0078
695 HAEMORRHOIDS 150 0.0077
696 PHARYNGITIS 95 0.0077
697 TOXICITY TO VARIOUS AGENTS 1287 0.0076
698 THERAPY NON-RESPONDER 341 0.0076
699 DELIRIUM 263 0.0076
700 HYPOAESTHESIA 1125 0.0075
701 PAIN IN JAW 211 0.0074
702 POST PROCEDURAL COMPLICATION 143 0.0074
703 PARAESTHESIA ORAL 106 0.0073
704 LIVER FUNCTION TEST ABNORMAL 213 0.0073
705 COLD SWEAT 129 0.0073
706 RETINAL DETACHMENT 67 0.0073
707 ANGINA PECTORIS 208 0.0073
708 GASTROINTESTINAL HAEMORRHAGE 606 0.0072
709 EMPHYSEMA 73 0.0072
710 CARDIOMEGALY 89 0.0072
711 DEATH 6176 0.0072
712 EPILEPSY 218 0.0071
713 PALLOR 194 0.0071
714 PREMATURE BABY 214 0.0071
715 THYROID DISORDER 109 0.0071
716 SKIN FISSURES 138 0.0071
717 HYPERHIDROSIS 906 0.0070
718 LOSS OF CONSCIOUSNESS 886 0.0069
719 LETHARGY 396 0.0069
720 TOOTH ABSCESS 70 0.0069
721 SUBARACHNOID HAEMORRHAGE 70 0.0069
722 FOLLICULITIS 72 0.0069
723 MUSCULAR WEAKNESS 773 0.0068
724 TOOTHACHE 123 0.0068
725 RENAL FAILURE 898 0.0068
726 TOOTH INFECTION 89 0.0067
727 CEREBRAL HAEMORRHAGE 241 0.0067
728 TENDERNESS 70 0.0067
729 URINARY INCONTINENCE 199 0.0067
730 SQUAMOUS CELL CARCINOMA 63 0.0067
731 NO THERAPEUTIC RESPONSE 81 0.0066
732 COAGULOPATHY 110 0.0066
733 HEPATIC ENZYME INCREASED 441 0.0065
734 PRODUCTIVE COUGH 308 0.0064
735 RASH ERYTHEMATOUS 308 0.0064
736 NODULE 84 0.0064
737 HEPATIC ENCEPHALOPATHY 60 0.0064
738 HAEMORRHAGE INTRACRANIAL 96 0.0064
739 VERTIGO 390 0.0064
740 DRUG INTERACTION 1015 0.0064
741 APHASIA 193 0.0064
742 PELVIC PAIN 116 0.0064
743 PERICARDITIS 107 0.0064
744 PLATELET COUNT INCREASED 83 0.0064
745 UPPER RESPIRATORY TRACT INFECTION 294 0.0064
746 VISUAL ACUITY REDUCED 211 0.0063
747 SCHIZOPHRENIA 77 0.0063
748 BACTERIAL INFECTION 118 0.0063
749 ARRHYTHMIA 299 0.0063
750 HAEMATOMA 163 0.0063
751 THROMBOSIS 504 0.0063
752 DIVERTICULITIS 173 0.0062
753 SPLENOMEGALY 73 0.0062
754 ULCER 99 0.0062
755 SARS-COV-2 TEST POSITIVE 82 0.0062
756 INCONTINENCE 65 0.0061
757 ABDOMINAL PAIN LOWER 155 0.0061
758 RESPIRATORY DISORDER 183 0.0061
759 MUSCULOSKELETAL PAIN 320 0.0061
760 WEIGHT DECREASED 1704 0.0061
761 GASTROINTESTINAL PAIN 67 0.0061
762 NERVOUS SYSTEM DISORDER 190 0.0061
763 METABOLIC ACIDOSIS 194 0.0061
764 COGNITIVE DISORDER 283 0.0061
765 DYSPHONIA 352 0.0060
766 COVID-19 PNEUMONIA 71 0.0060
767 CARDIOVASCULAR DISORDER 152 0.0060
768 PULMONARY HYPERTENSION 124 0.0059
769 PAIN 3656 0.0059
770 DYSPEPSIA 577 0.0059
771 SKIN EXFOLIATION 493 0.0058
772 DEVICE OCCLUSION 82 0.0058
773 TREATMENT FAILURE 481 0.0058
774 MALAISE 2543 0.0058
775 MICTURITION URGENCY 66 0.0058
776 PULMONARY CONGESTION 76 0.0058
777 INTENTIONAL PRODUCT USE ISSUE 505 0.0058
778 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 409 0.0057
779 HEMIPARESIS 97 0.0057
780 MASS 80 0.0057
781 INFLAMMATION 295 0.0057
782 EYE PAIN 322 0.0057
783 VENTRICULAR TACHYCARDIA 94 0.0057
784 CARDIAC FAILURE CONGESTIVE 456 0.0057
785 FRACTURE 107 0.0056
786 ABDOMINAL PAIN UPPER 1155 0.0056
787 GENERALISED TONIC-CLONIC SEIZURE 91 0.0055
788 BLOOD PRESSURE INCREASED 835 0.0055
789 THERAPEUTIC RESPONSE DECREASED 331 0.0055
790 PALPITATIONS 636 0.0054
791 DRY EYE 270 0.0054
792 HYPOAESTHESIA ORAL 81 0.0054
793 DEAFNESS 139 0.0053
794 ARTHRALGIA 2208 0.0053
795 PRURITUS 1995 0.0052
796 RESPIRATORY ARREST 143 0.0052
797 HALLUCINATION, AUDITORY 82 0.0052
798 BLOOD CREATINE PHOSPHOKINASE INCREASED 148 0.0051
799 BLOOD PRESSURE SYSTOLIC INCREASED 100 0.0051
800 ECZEMA 267 0.0051
801 PERIPHERAL COLDNESS 70 0.0051
802 DEPRESSION 1158 0.0051
803 RASH PRURITIC 275 0.0051
804 PROSTATE CANCER 408 0.0051
805 SEIZURE 584 0.0051
806 CYTOMEGALOVIRUS INFECTION 83 0.0050
807 ELECTROCARDIOGRAM QT PROLONGED 178 0.0049
808 OSTEOPENIA 75 0.0049
809 FEEDING DISORDER 100 0.0049
810 BLOOD PRESSURE ABNORMAL 98 0.0049
811 PULMONARY ARTERIAL HYPERTENSION 70 0.0048
812 ADVERSE EVENT 445 0.0048
813 DYSARTHRIA 181 0.0048
814 AMENORRHOEA 84 0.0048
815 BLISTER 269 0.0048
816 ABDOMINAL DISTENSION 499 0.0048
817 BRADYCARDIA 253 0.0048
818 OROPHARYNGEAL PAIN 433 0.0047
819 MUSCLE ATROPHY 59 0.0047
820 DISORIENTATION 184 0.0046
821 AGEUSIA 115 0.0046
822 EATING DISORDER 98 0.0046
823 HAEMORRHAGE 481 0.0046
824 DRY MOUTH 373 0.0046
825 ILL-DEFINED DISORDER 277 0.0046
826 CONDITION AGGRAVATED 1377 0.0045
827 INTERNATIONAL NORMALISED RATIO INCREASED 129 0.0045
828 CONFUSIONAL STATE 729 0.0045
829 ORAL HERPES 88 0.0045
830 BLOOD TEST ABNORMAL 63 0.0045
831 HERPES ZOSTER 257 0.0045
832 DIZZINESS 2229 0.0045
833 RHABDOMYOLYSIS 186 0.0045
834 PAIN IN EXTREMITY 1314 0.0045
835 RESTLESSNESS 163 0.0044
836 MUSCULOSKELETAL DISCOMFORT 76 0.0044
837 VISION BLURRED 605 0.0044
838 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 238 0.0043
839 CHOLELITHIASIS 142 0.0043
840 IMPAIRED GASTRIC EMPTYING 59 0.0043
841 GASTROOESOPHAGEAL REFLUX DISEASE 344 0.0043
842 FULL BLOOD COUNT DECREASED 86 0.0043
843 HEART RATE INCREASED 421 0.0042
844 HAEMATOCHEZIA 234 0.0042
845 IMMUNODEFICIENCY 63 0.0042
846 EAR PAIN 82 0.0042
847 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220 0.0042
848 LUNG NEOPLASM MALIGNANT 173 0.0042
849 FOETAL EXPOSURE DURING PREGNANCY 335 0.0041
850 THROAT IRRITATION 183 0.0041
851 PANCREATITIS 215 0.0041
852 RIB FRACTURE 82 0.0040
853 WHEEZING 236 0.0040
854 NEOPLASM MALIGNANT 264 0.0040
855 EOSINOPHILIA 69 0.0039
856 HYPOKINESIA 57 0.0039
857 DEPRESSED MOOD 206 0.0039
858 RASH PAPULAR 87 0.0039
859 HYPOGLYCAEMIA 187 0.0039
860 RHINORRHOEA 244 0.0038
861 BRONCHITIS 277 0.0037
862 FEELING COLD 104 0.0037
863 RETCHING 79 0.0037
864 BRAIN FOG 58 0.0037
865 BLOOD POTASSIUM INCREASED 60 0.0037
866 MATERNAL EXPOSURE DURING PREGNANCY 329 0.0037
867 INSOMNIA 968 0.0036
868 SWELLING FACE 236 0.0036
869 PRESCRIBED UNDERDOSE 72 0.0036
870 HEART RATE DECREASED 126 0.0036
871 SKIN DISCOLOURATION 163 0.0035
872 HEART RATE IRREGULAR 80 0.0035
873 PRODUCT PRESCRIBING ISSUE 77 0.0035
874 PAIN OF SKIN 94 0.0035
875 POLLAKIURIA 145 0.0035
876 JOINT STIFFNESS 91 0.0035
877 CORONARY ARTERY DISEASE 104 0.0034
878 GASTRIC CANCER 87 0.0034
879 RENAL DISORDER 159 0.0034
880 EXTRAPYRAMIDAL DISORDER 84 0.0034
881 CATARACT 198 0.0033
882 NIGHT SWEATS 107 0.0033
883 PSYCHOTIC DISORDER 98 0.0033
884 DRY SKIN 440 0.0033
885 SPINAL FRACTURE 66 0.0033
886 TRANSIENT ISCHAEMIC ATTACK 111 0.0033
887 PRODUCT USE ISSUE 616 0.0033
888 DRUG INEFFECTIVE 4314 0.0033
889 VAGINAL HAEMORRHAGE 142 0.0033
890 HEADACHE 2050 0.0033
891 LIMB DISCOMFORT 101 0.0033
892 FEMUR FRACTURE 101 0.0033
893 EXPOSURE DURING PREGNANCY 199 0.0032
894 URTICARIA 536 0.0032
895 DRUG EFFECT INCOMPLETE 115 0.0032
896 LACTIC ACIDOSIS 102 0.0031
897 NECK PAIN 176 0.0031
898 PERIPHERAL SWELLING 483 0.0031
899 DIABETES MELLITUS 237 0.0031
900 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 91 0.0031
901 TOOTH LOSS 64 0.0031
902 VISUAL IMPAIRMENT 381 0.0031
903 FUNGAL INFECTION 102 0.0031
904 GAIT DISTURBANCE 583 0.0030
905 SWELLING 283 0.0030
906 FALL 1005 0.0030
907 BURNING SENSATION 211 0.0030
908 WOUND 84 0.0030
909 INFLUENZA LIKE ILLNESS 246 0.0030
910 MUSCLE TWITCHING 68 0.0029
911 COVID-19 517 0.0029
912 SOMNOLENCE 591 0.0029
913 BALANCE DISORDER 252 0.0029
914 LABORATORY TEST ABNORMAL 86 0.0029
915 SPEECH DISORDER 151 0.0029
916 TOOTH DISORDER 64 0.0029
917 LIP SWELLING 95 0.0028
918 TREMOR 473 0.0028
919 OSTEOPOROSIS 116 0.0028
920 MUSCLE SPASMS 517 0.0028
921 GLOSSODYNIA 63 0.0028
922 HYPOACUSIS 121 0.0028
923 CEREBROVASCULAR ACCIDENT 472 0.0028
924 MENTAL DISORDER 121 0.0028
925 DISTURBANCE IN ATTENTION 148 0.0027
926 FLUID RETENTION 139 0.0027
927 SLEEP DISORDER 192 0.0027
928 TYPE 2 DIABETES MELLITUS 91 0.0027
929 CONVULSION 154 0.0027
930 RASH MACULAR 94 0.0027
931 LOCALISED INFECTION 65 0.0027
932 ADVERSE DRUG REACTION 239 0.0027
933 COLITIS ULCERATIVE 118 0.0026
934 SNEEZING 59 0.0026
935 OSTEOARTHRITIS 111 0.0026
936 MYOCARDIAL INFARCTION 451 0.0026
937 GAIT INABILITY 85 0.0025
938 DYSSTASIA 74 0.0025
939 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
940 UNDERDOSE 180 0.0025
941 ABDOMINAL DISCOMFORT 410 0.0024
942 CARDIAC DISORDER 227 0.0024
943 ANGIOEDEMA 107 0.0024
944 VIRAL INFECTION 80 0.0024
945 BREAST CANCER FEMALE 64 0.0024
946 AGITATION 173 0.0024
947 MOVEMENT DISORDER 75 0.0023
948 NASOPHARYNGITIS 405 0.0022
949 DEMENTIA 60 0.0021
950 RENAL INJURY 63 0.0021
951 FLATULENCE 118 0.0021
952 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 99 0.0021
953 MEMORY IMPAIRMENT 274 0.0020
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 353 0.0020
955 CHRONIC KIDNEY DISEASE 142 0.0019
956 ARTHRITIS 146 0.0019
957 SINUSITIS 188 0.0018
958 AMNESIA 117 0.0018
959 PANIC ATTACK 65 0.0018
960 CONTUSION 170 0.0018
961 MUSCULOSKELETAL STIFFNESS 154 0.0018
962 EYE DISORDER 57 0.0017
963 UNEVALUABLE EVENT 131 0.0017
964 NASAL CONGESTION 99 0.0017
965 TREATMENT NONCOMPLIANCE 92 0.0017
966 OCULAR HYPERAEMIA 78 0.0016
967 SURGERY 96 0.0016
968 MOBILITY DECREASED 107 0.0015
969 INFLUENZA 165 0.0015
970 WEIGHT INCREASED 330 0.0015
971 HALLUCINATION 110 0.0015
972 MEDICATION ERROR 79 0.0014
973 BLOOD GLUCOSE INCREASED 265 0.0014
974 ASTHMA 156 0.0014
975 THERAPY CESSATION 68 0.0013
976 FEELING ABNORMAL 317 0.0013
977 OVERDOSE 283 0.0013
978 EYE IRRITATION 75 0.0013
979 JOINT SWELLING 157 0.0013
980 INTENTIONAL PRODUCT MISUSE 109 0.0012
981 HOSPITALISATION 184 0.0012
982 ARTHROPATHY 65 0.0012
983 SKIN BURNING SENSATION 75 0.0010
984 ILLNESS 102 0.0010
985 PSORIASIS 118 0.0009
986 MIGRAINE 83 0.0009
987 SUICIDAL IDEATION 78 0.0009
988 NO ADVERSE EVENT 134 0.0007
989 INCORRECT DOSE ADMINISTERED 161 0.0007
990 PRODUCT QUALITY ISSUE 78 0.0006
991 RHEUMATOID ARTHRITIS 65 0.0006
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
993 PRODUCT DOSE OMISSION ISSUE 109 0.0004
994 INJECTION SITE PAIN 103 0.0003